Israel’s Immunai could be the secret weapon to faster drug approvals
American-Israeli company announces latest success story with AstraZeneca.
 Noam Solomon speaks at the Jerusalem Post's Global Investment Forum in June 2021(photo credit: MARC ISRAEL SELLEM)Updated:
 Noam Solomon speaks at the Jerusalem Post's Global Investment Forum in June 2021(photo credit: MARC ISRAEL SELLEM)Updated: